BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22008048)

  • 1. Pharmacogenomics and epilepsy: the road ahead.
    Cavalleri GL; McCormack M; Alhusaini S; Chaila E; Delanty N
    Pharmacogenomics; 2011 Oct; 12(10):1429-47. PubMed ID: 22008048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epilepsy pharmacogenetics : science or fiction?].
    Depondt C
    Med Sci (Paris); 2013 Feb; 29(2):189-93. PubMed ID: 23452606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epilepsy pharmacogenetics.
    Kasperaviciūte D; Sisodiya SM
    Pharmacogenomics; 2009 May; 10(5):817-36. PubMed ID: 19450130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacogenomics of epilepsy.
    Franco V; Perucca E
    Expert Rev Neurother; 2015 Oct; 15(10):1161-70. PubMed ID: 26327193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on pharmacogenetics in epilepsy: a brief review.
    Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ
    Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.
    Depondt C; Shorvon SD
    Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
    Ferraro TN; Buono RJ
    Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of epilepsy: new armamentarium, new issues.
    Vajda FJ
    J Clin Neurosci; 2007 Sep; 14(9):813-23. PubMed ID: 17618119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of pharmacogenetics in the treatment of epilepsy.
    Depondt C
    Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drug treatment in children.
    Hadjiloizou SM; Bourgeois BF
    Expert Rev Neurother; 2007 Feb; 7(2):179-93. PubMed ID: 17286551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients.
    Haerian BS; Lim KS; Tan HJ; Mohamed EH; Tan CT; Raymond AA; Wong CP; Wong SW; Omar H; Roslan H; Mohamed Z
    Epileptic Disord; 2011 Mar; 13(1):65-75. PubMed ID: 21388909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory epilepsy: clinical overview.
    French JA
    Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predisposition to epilepsy--does the ABCB1 gene play a role?
    Nurmohamed L; Garcia-Bournissen F; Buono RJ; Shannon MW; Finkelstein Y
    Epilepsia; 2010 Sep; 51(9):1882-5. PubMed ID: 20491876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenetics, pharmacogenomics and individualised antiepileptic therapy].
    Herranz JL
    Rev Neurol; 2006 Oct; 43 Suppl 1():S43-9. PubMed ID: 17061195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in the treatment of epilepsy.
    Clancy CE; Kass RS
    Pharmacogenomics; 2003 Nov; 4(6):747-51. PubMed ID: 14596638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics.
    Holmes GL
    Epilepsy Res; 2002 Jun; 50(1-2):41-54. PubMed ID: 12151116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating antiepileptic drug treatment and characteristics of drugs.
    Bourgeois BF
    Handb Clin Neurol; 2013; 111():719-25. PubMed ID: 23622219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of epilepsy in adolescents and adults.
    Brodie MJ; French JA
    Lancet; 2000 Jul; 356(9226):323-9. PubMed ID: 11071202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy.
    Kim WJ; Lee JH; Yi J; Cho YJ; Heo K; Lee SH; Kim SW; Kim MK; Kim KH; In Lee B; Lee MG
    Pharmacogenet Genomics; 2010 Apr; 20(4):249-56. PubMed ID: 20216337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
    Rogawski MA
    Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.